Funder directory / Switzerland / Venture capital firms
Nextech Invest
Nextech Invest is a Zurich-based venture capital firm that invests in emerging biotechnology companies worldwide. It focuses on identifying and supporting transformative cancer medicines and advances in precision medicine.
StagesNot stated
Deals recorded9
What they invest in
All investments and operations
9 operations| Company | Round | Amount | Date | Co-investors | Source |
|---|---|---|---|---|---|
| A2 Biotherapeutics US | – | – | – | – | Portfolio page |
| AiRNA US | – | – | – | – | Portfolio page |
| Alpha-9 Oncology CA | – | – | – | – | Portfolio page |
| Alterome Therapeutics | – | – | – | – | Portfolio page |
| Alumis | – | – | – | – | Portfolio page |
| Ambagon Therapeutics | – | – | – | – | Portfolio page |
| Ambrx Biopharma | – | – | – | – | Portfolio page |
| Arrakis Therapeutics US | – | – | – | – | Portfolio page |
| ARS Pharmaceuticals | – | – | – | – | Portfolio page |
Exits
- Ambrx Biopharma Acquired by Johnson & Johnson2024 · Source
Shown only when an exit is documented by a public source.
Similar funders
- ACE Ventures · Venture capital, Switzerland
- Alpana Ventures · Venture capital, Switzerland
- Arcanys Ventures · Venture capital, Switzerland
- b2venture · Venture capital, Switzerland
- BioMedPartners · Venture capital, Switzerland
- BlueOcean Ventures · Venture capital, Switzerland